touchpodcast

touchPODCAST

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005!We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updatesHome...

Autor

touchpodcast

Categoría

Science

Web del podcast

touchpodcast.podbean.com

Último episodio

9 de jul. de 2026

¿Dónde escuchar?

Podcasts en la app Replaio Radio Muy pronto

Los podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts

Descárgala en Google Play Instálala gratis Android 5 M+ de descargas · valoración de 4,8 iOS muy pronto

Episodios

Targeting pathogenic mechanisms in gMG: From complement- and FcRn-directed therapies to B- and T-cell-targeted approaches 09.07.2026

touchTALKS for touchNEUROLOGY Listen to an autoimmune neuromuscular disease expert review the unmet needs for patients with generalized myasthenia gravis and explain how emerging targeted therapies address underlying disease mechanisms to improve patient outcomes. The expert Dr. Richard Nowak, Yale School of Medicine, New Haven, CT, USA This touchPODCAST is for healthcare professionals outside of...

The art and science of presbyopia-correcting intraocular lens selection: From preoperative planning to patient satisfaction 09.07.2026

touchCASES for touchOPHTHALMOLOGY Listen to two experts as they discuss three cases illustrating the art and science of presbyopia-correcting intraocular lens (IOL) selection, from preoperative planning to patient satisfaction. They examine key decision points from preoperative assessment and clinical workup to presbyopia-correcting IOL selection in routine and complex cases. The experts: Dr. Dagn...

Unraveling the cortisol connection: Hard-to-control hypertension and hyperglycemia 08.07.2026

touchTALKS for touchENDOCRINOLOGY Listen to Dr. Richard Auchus, as he describes how hypercortisolism can lead to hyperglycemia and hypertension, and discusses how to recognize, screen, and manage hypercortisolism in at-risk patient populations. The expert Dr Richard J. Auchus, University of Michigan, Ann Arbor, MI, USA. This touchPODCAST is for HCPs in the USA only. This activity is funded by an i...

Reducing attrition and maximizing ADC impact in metastatic breast cancer 07.07.2026

touchIN CONVERSATION for touchONCOLOGY Identifying patients at risk of treatment attrition is an important part of treatment decision-making, as these patients may miss opportunities to receive subsequent treatments that could improve survival and quality of life. Listen to breast cancer experts consider the impact of treatment attrition in metastatic breast cancer and review evidence supporting t...

The art of diagnosing CIDP: Strengthening diagnostic confidence 06.07.2026

touchCASES for touchNEUROLOGY Hear from two European experts as they discuss how to strengthen diagnostic confidence in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Through three patient cases, they address how to recognize and differentiate CIDP variants from other polyneuropathies and consider how key diagnostic criteria can be applied to reinforce diagnostic c...

The key to ketoacidosis: Unlocking the potential for better DKA monitoring and detection 06.07.2026

touchEXPERT FOCUS for touchENDOCRINOLOGY Listen to a series of interviews with Dr. Eden Miller who will provide her expert insights into the recognition of typical and euglycemic diabetic ketoacidosis (DKA), the current and emerging ketone monitoring methods, including continuous ketone monitoring and the importance of optimizing patient and caregiver education to reduce preventable DKA events and...

Optimizing outcomes in advanced endometrial carcinoma: Navigating guidelines, biomarker-driven immunotherapy and irAE management 15.06.2026

touchCASES for touchONCOLOGY Join two international experts as they walk through three real-world patient stories, showing how molecular testing shapes treatment choices in advanced endometrial cancer and how immune-related side effects can be recognized and managed in everyday practice.      The experts: Dr Nicoletta Colombo, European Institute of Oncology, Milan, Italy Dr Ilaria Colombo, Oncolog...

Personalizing cataract surgery: From pre-operative precision to functional vision outcomes 21.05.2026

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with a leading expert in cataract surgery. Dr Filomena Ribeiro shares insights on the latest advances in pre-operative assessment, AI-enhanced IOL power calculation and functional depth-of-field (DOFi)-based lens selection, as well as emerging IOL materials and technologies. She also provides practical guidance on pati...

Cracking the code of CIDP: Mastering diagnostic precision 05.05.2026

touchCASES for touchNEUROLOGY Listen to two US-based experts as they discuss how to improve diagnostic accuracy in the USA for patients with chronic inflammatory demyelinating polyneuropathy (CIDP). They will discuss three patient cases to illustrate how to recognize and differentiate CIDP variants from other polyneuropathies, and apply key diagnostic criteria to help strengthen a diagnosis. The e...

Looking beyond VEGF to target BRB dysfunction in DME: Novel approaches to prevent vision loss 29.04.2026

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of interviews with Dr. Diana Do as she shares her expert insights into the epidemiology and quality‑of‑life burden of diabetic macular edema (DME) in the USA, outlines real‑world limitations of current anti‑VEGF–based management, and examines emerging therapies that specifically target blood–retinal barrier (BRB) dysfunction and aim to pr...

Unlocking new potential: Rationale and evidence for dual EZH2/AR inhibition in mCRPC 28.04.2026

touchTALKS for touchONCOLOGY Listen to Dr Teresa Alonso-Gordoa, as she evaluates the latest data on dual EZH2/AR inhibition in mCRPC and explores how emerging evidence could influence clinical decision-making in the future. The expert Dr. Teresa Alonso-Gordoa - Hospital Universitario Ramón y Cajal, Madrid, Spain This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an in...

Integrating neurosensory pathway insights into modern dry eye management 23.04.2026

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with three leading experts discussing neural-targeted therapies for dry eye disease (DED). The faculty describe the neuronal control of tear secretion, explore the mechanisms of action and clinical findings with neuromodulatory/neurostimulatory therapies for DED, and discuss how to integrate these therapies into person...

Computational pathology in NSCLC: From biomarker discovery to clinical integration 23.04.2026

touchEXPERT FOCUS for touchONCOLOGY and touchRESPIRATORY   Listen to a series of short interviews with leading experts on computational pathology in NSCLC. The faculty, an oncologist, an oncologist-researcher and a pathologist, discuss the clinical value of computational pathology in NSCLC, review emerging tools and share practical insights on how these approaches can be applied in routine patient...

Shaping the future of PDAC care: Scientific advances and therapeutic innovation 21.04.2026

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the future of care for patients with pancreatic ductal adenocarcinoma, or PDAC.  The faculty provide their insights on the current unmet needs, the evolving role of imaging, biomarker testing, and treatment strategies, and how these developments may impact clinical care. The experts: Dr Eileen O'Reilly - Memorial...

Exploring all angles: Neuroprotective strategies beyond IOP in primary and steroid-induced open-angle glaucoma 31.03.2026

touchEXPERT FOCUS for touchOPHTHALMOLOGY   Listen to a series of interviews with Dr Maria-João Menéres who will provide her expert insights into the mechanisms of retinal ganglion cell (RGC) damage in both primary open-angle and secondary, steroid-induced glaucoma, and the importance of neuroprotection to mitigate the risk of glaucoma development or progression. The expert: Dr Maria-João Menéres,...

Optimizing presbyopia-correcting IOL selection and patient expectations 23.03.2026

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen as Prof. Sumit (Sam) Garg shares expert clinical insights on how AI-supported biometric analysis can increase refractive accuracy and support confident presbyopia-correcting IOL selection, including which patient and ocular characteristics are most likely to benefit from AI-based tools. He also outlines practical strategies for structuring preoperati...

Advancing outcomes in CP-CML: Guideline-directed approaches to treatment decision-making, monitoring and toxicity management 20.03.2026

touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY Listen to leading experts discuss guideline-directed strategies for mutational analysis and monitoring response when treating patients with chronic-phase chronic myeloid leukaemia with approved tyrosine kinase inhibitors. The experts Dr Jorge Cortes, Georgia Cancer Center, Augusta, GA, USA Dr Elias Jabbour, MD Anderson Cancer Center, Hou...

The bare necessities of hyperphagia in Prader–Willi syndrome: Expert insights on recognition and management 09.03.2026

touchEXPERT FOCUS for touchENDOCRINOLOGY Listen to a series of short interviews with paediatric endocrinologist Dr Ashley Shoemaker as she discusses the clinical manifestations and pathophysiology of Prader–Willi syndrome (PWS), with a focus on hyperphagia by exploring the spectrum across the lifespan of PWS and shares best practices for managing PWS-related hyperphagia within a multidisciplinary...

Targeting brain metastases in advanced NSCLC: The emerging impact of ADCs 05.03.2026

touchPANEL DISCUSSION for touchONCOLOGY and touchRESPIRATORY   Listen to leading experts discuss the role of antibody–drug conjugates (ADCs) in NSCLC with brain metastases, including the latest clinical trial evidence, practical approaches to patient selection and treatment sequencing alongside local CNS therapies, and the evolving pipeline of investigational ADCs. The expert(s) Dr Lyudmila Bazhen...

Evolving paradigms in PNH management: Interpreting the latest data 25.02.2026

touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY Listen to a panel of leading experts as they explore the latest advances in PNH pathophysiology, diagnostic approaches and therapeutic strategies, including data from ASH 2025, with practical insights for contemporary clinical practice. The experts: Prof. Bruno Fattizzo, Università degli Studi di Milano, Milan, Italy Dr Austin Kulasekara...

Diagnosis, multidisciplinary monitoring and individualized management in LOPD 21.01.2026

touchCASES for touchNEUROLOGY, touchCARDIO, touchENDOCRINOLOGY and touchRESPIRATORY Listen to two experts as they discuss three cases illustrating the heterogeneous, multisystem nature of late-onset Pompe disease (LOPD). They examine key decision points from recognizing early clinical clues and confirming diagnosis to optimizing enzyme replacement therapy (ERT), monitoring progression and coordina...

Unlocking the possibilities of BCMA-directed therapies in RRMM: Latest perspectives from IMS and ASH 2025 21.01.2026

touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY Listen to multiple myeloma expert Dr Rakesh Popat review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the International Multiple Society (IMS) and American Society of Hematology (ASH) 2025 congresses. Dr Popat is then joined by fellow experts Dr Paula Rodríguez-Otero and Dr Roberto Mina...

Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC 15.01.2026

touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging...

Evolving strategies in low-grade serous ovarian cancer: Applying the evidence to optimize patient care 15.01.2026

touchEXPERT FOCUS for touchONCOLOGY Listen to insights from Dr Kathleen Moore on the pathophysiology and molecular features of low-grade serous ovarian cancer (LGSOC) and how it differs from other ovarian cancers. She also discusses evidence-based treatment options and sequencing, as well as practical considerations relating to administration and side-effect management. The expert: Dr Kathleen Moo...

Managing cytopenias: The path to transfusion independence for patients with myelofibrosis 05.12.2025

touchIN CONVERSATION for touchHAEMATOLOGY The presence of anaemia and/or thrombocytopenia complicates the management of patients with myelofibrosis (MF). Listen to expert haematologists consider the burden of cytopenias in patients with MF and discuss strategies to reduce transfusion dependence, improve splenomegaly and personalize treatment with JAK inhibitors. The experts Prof. Claire Harrison,...

Escucha el podcast touchPODCAST en Replaio

Radio y podcasts en una sola app - gratis y sin registro. Instálala hoy y no te pierdas el estreno

Descárgala en Google Play

Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos